Search
00
GBAF Logo
trophy
Top StoriesInterviewsBusinessFinanceBankingTechnologyInvestingTradingVideosAwardsMagazinesHeadlinesTrends

Subscribe to our newsletter

Get the latest news and updates from our team.

Global Banking & Finance Review®

Global Banking & Finance Review® - Subscribe to our newsletter

Company

    GBAF Logo
    • About Us
    • Profile
    • Privacy & Cookie Policy
    • Terms of Use
    • Contact Us
    • Advertising
    • Submit Post
    • Latest News
    • Research Reports
    • Press Release
    • Awards▾
      • About the Awards
      • Awards TimeTable
      • Submit Nominations
      • Testimonials
      • Media Room
      • Award Winners
      • FAQ
    • Magazines▾
      • Global Banking & Finance Review Magazine Issue 79
      • Global Banking & Finance Review Magazine Issue 78
      • Global Banking & Finance Review Magazine Issue 77
      • Global Banking & Finance Review Magazine Issue 76
      • Global Banking & Finance Review Magazine Issue 75
      • Global Banking & Finance Review Magazine Issue 73
      • Global Banking & Finance Review Magazine Issue 71
      • Global Banking & Finance Review Magazine Issue 70
      • Global Banking & Finance Review Magazine Issue 69
      • Global Banking & Finance Review Magazine Issue 66
    Top StoriesInterviewsBusinessFinanceBankingTechnologyInvestingTradingVideosAwardsMagazinesHeadlinesTrends

    Global Banking & Finance Review® is a leading financial portal and online magazine offering News, Analysis, Opinion, Reviews, Interviews & Videos from the world of Banking, Finance, Business, Trading, Technology, Investing, Brokerage, Foreign Exchange, Tax & Legal, Islamic Finance, Asset & Wealth Management.
    Copyright © 2010-2026 GBAF Publications Ltd - All Rights Reserved. | Sitemap | Tags | Developed By eCorpIT

    Editorial & Advertiser disclosure

    Global Banking & Finance Review® is an online platform offering news, analysis, and opinion on the latest trends, developments, and innovations in the banking and finance industry worldwide. The platform covers a diverse range of topics, including banking, insurance, investment, wealth management, fintech, and regulatory issues. The website publishes news, press releases, opinion and advertorials on various financial organizations, products and services which are commissioned from various Companies, Organizations, PR agencies, Bloggers etc. These commissioned articles are commercial in nature. This is not to be considered as financial advice and should be considered only for information purposes. It does not reflect the views or opinion of our website and is not to be considered an endorsement or a recommendation. We cannot guarantee the accuracy or applicability of any information provided with respect to your individual or personal circumstances. Please seek Professional advice from a qualified professional before making any financial decisions. We link to various third-party websites, affiliate sales networks, and to our advertising partners websites. When you view or click on certain links available on our articles, our partners may compensate us for displaying the content to you or make a purchase or fill a form. This will not incur any additional charges to you. To make things simpler for you to identity or distinguish advertised or sponsored articles or links, you may consider all articles or links hosted on our site as a commercial article placement. We will not be responsible for any loss you may suffer as a result of any omission or inaccuracy on the website.

    Home > Finance > AstraZeneca hits record high, cements lead as UK's biggest stock
    Finance

    AstraZeneca hits record high, cements lead as UK's biggest stock

    Published by Global Banking & Finance Review®

    Posted on November 11, 2025

    1 min read

    Last updated: January 21, 2026

    AstraZeneca hits record high, cements lead as UK's biggest stock - Finance news and analysis from Global Banking & Finance Review
    Why waste money on news and opinion when you can access them for free?

    Take advantage of our newsletter subscription and stay informed on the go!

    Subscribe

    Tags:equitymarket capitalisationfinancial community

    Quick Summary

    AstraZeneca shares hit a record high, cementing its lead as the UK's largest stock. The surge follows strong earnings and a US drug-pricing deal.

    Table of Contents

    • AstraZeneca's Market Performance
    • Recent Earnings and Market Reaction
    • Impact of U.S. Drug-Pricing Deal
    • FTSE Index Movement

    AstraZeneca Shares Reach All-Time High, Dominating UK Market

    AstraZeneca's Market Performance

    (Reuters) -Shares in AstraZeneca rose past their September 2024 peak on Tuesday, hitting a fresh record high and cementing the company's position as the largest UK-listed stock by market value.

    Recent Earnings and Market Reaction

    Tuesday's surge added to the rally after forecast-beating quarterly earnings last week and a U.S. drug-pricing deal in October that helped remove some policy uncertainty. The United States accounts for more than 40% of AstraZeneca's total sales.

    Impact of U.S. Drug-Pricing Deal

    By 0832 GMT, AstraZeneca was up 2.5% after surging to as high as 134.6 pounds, giving it a market value of close to 210 billion pounds ($282 billion).  The blue-chip FTSE index, meanwhile, rose 1.1% to new record highs of its own, after UK labour market data boosted expectations for a Bank of England rate cut next month.

    FTSE Index Movement

    ($1 = 0.7451 pounds)

    (Reporting by Danilo Masoni; Editing by Amanda Cooper)

    Key Takeaways

    • •AstraZeneca shares hit a record high, surpassing the September 2024 peak.
    • •The company's market value nears 210 billion pounds.
    • •US drug-pricing deal boosts investor confidence.
    • •FTSE index also reaches new highs amid UK labor data.
    • •Bank of England rate cut expectations rise.

    Frequently Asked Questions about AstraZeneca hits record high, cements lead as UK's biggest stock

    1What is market capitalisation?

    Market capitalisation is the total market value of a company's outstanding shares of stock. It is calculated by multiplying the current share price by the total number of outstanding shares.

    2What are quarterly earnings?

    Quarterly earnings refer to a company's financial performance over a three-month period. These results are reported to shareholders and can impact stock prices and investor perception.

    3What is a blue-chip stock?

    A blue-chip stock is a share in a well-established company with a history of stable earnings and reliable growth. These companies typically have a strong reputation and are considered safe investments.

    4What is the FTSE index?

    The FTSE index, or Financial Times Stock Exchange index, is a stock market index that tracks the performance of the 100 largest companies listed on the London Stock Exchange.

    More from Finance

    Explore more articles in the Finance category

    Image for French miner Eramet's finance chief steps aside temporarily, days after CEO ouster
    French miner Eramet's finance chief steps aside temporarily, days after CEO ouster
    Image for Ukraine's Zelenskiy calls for faster action on air defence, repairs to grid
    Ukraine's Zelenskiy calls for faster action on air defence, repairs to grid
    Image for Goldman Sachs teams up with Anthropic to automate banking tasks with AI agents, CNBC reports
    Goldman Sachs teams up with Anthropic to automate banking tasks with AI agents, CNBC reports
    Image for Analysis-Hims' $49 weight-loss pill rattles investor case for cash-pay obesity market
    Analysis-Hims' $49 weight-loss pill rattles investor case for cash-pay obesity market
    Image for Analysis-Glencore to focus on short-term disposals as Rio deal remains elusive
    Analysis-Glencore to focus on short-term disposals as Rio deal remains elusive
    Image for Belgium's Agomab Therapeutics valued at $716 million as shares fall in Nasdaq debut
    Belgium's Agomab Therapeutics valued at $716 million as shares fall in Nasdaq debut
    Image for Big Tech's quarter in four charts: AI splurge and cloud growth
    Big Tech's quarter in four charts: AI splurge and cloud growth
    Image for EU hikes tariffs on Chinese ceramics to 79% to counter dumping 
    EU hikes tariffs on Chinese ceramics to 79% to counter dumping 
    Image for AI trade splinters as investors get more selective
    AI trade splinters as investors get more selective
    Image for EU extends tariff suspension on $109.8 billion of US imports for six months
    EU extends tariff suspension on $109.8 billion of US imports for six months
    Image for Dog food maker Ollie acquired by Spain’s Agrolimen
    Dog food maker Ollie acquired by Spain’s Agrolimen
    Image for Salzgitter to take over HKM steel joint venture, end clash with Thyssenkrupp
    Salzgitter to take over HKM steel joint venture, end clash with Thyssenkrupp
    View All Finance Posts
    Previous Finance PostUK grocery inflation slows to 4.7%, says Worldpanel
    Next Finance PostExclusive-Shell challenges arbitration decision on Venture Global LNG supply contracts